fomesafen has been researched along with Hepatitis C in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bussa, RM; Chaudhry, K; Cook, MR; Klausner, HA; Lee, MS; Manteuffel, JJ; Miller, JB; Rammal, JK; Ross, JE; Sabagha, NL; Samuel, LP; Sridasyam, K | 1 |
| Chao, WH; Chen, WM; Hsu, NT; Kee, KM; Lin, YC; Lu, SN; Wang, JH | 1 |
| Dalusim, F; Hussin, A; Ibrahim, N; Nor Rahim, MY; Othman, NI; Shahidan, MA; Yusof, R | 1 |
| Aguilera, A; Agulla, A; Cabrera, JJ; Cañizares, A; García-Campello, M; Gude, MJ; Moldes, LM; Navarro, D; Ordoñez, P; Rodriguez-Otero, L; Trigo, M; Vallejo, A | 1 |
| Alados, JC; Becerril, B; Cabezas, T; Cantudo, P; Casas, MP; Clavijo, E; de la Iglesia, A; Domínguez, A; Franco-Álvarez, F; Freyre-Carrillo, C; Galán, MÁ; García, F; García-Navarrete, Á; Guerrero, I; Guillot, V; Guzmán, A; Lozano, MDC; Luzón, P; Montiel, N; Muñoz, A; Palanca, M; Pérez-Santos, MJ; Ramírez-Arcos, M; Reguera, JA; Roldán, C; Romera, MA; Serrano, MDC; Torres, E; Vargas, J; Viciana, I | 1 |
| Aguilera, A; Blasco, AJ; Calleja, JL; Crespo, J; Eiros, JM; García, F; García-Samaniego, J; Lázaro, P | 1 |
| Ampuero, J; Fernández Rodríguez, CM; Herrero, JI | 1 |
| Biondi, MJ; Capraru, C; Casey, J; Feld, JJ; Fletcher, D; Gjevori, M; Hansen, BE; Hong, R; Janssen, HLA; Karkada, J; Lazarus, JV; Mandel, E; Ryan, P; Sattar, I; Shah, H; Smookler, D; Valencia, J; Vanderhoff, A | 1 |
| Chen, MY; Chen, WM; Hsu, NT; Huang, TJ; Huang, WC; Lee, CY; Lu, SN | 1 |
| Chang, KC; Chang, TS; Chen, MY; Chen, WM; Chiu, WN; Hsu, NT; Hu, JH; Huang, TJ; Huang, WC; Lee, CY; Lin, YC; Lu, SN | 1 |
10 other study(ies) available for fomesafen and Hepatitis C
| Article | Year |
|---|---|
Hepatitis C Virus Reflex Testing Protocol in an Emergency Department.
Topics: Emergency Service, Hospital; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Reflex | 2022 |
Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships.
Topics: Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Mass Screening; Reflex | 2022 |
True-positive reflex threshold value for HCV antibody screening test.
Topics: Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Immunoassay; Reflex; Sensitivity and Specificity | 2022 |
Generalized implementation of reflex testing of hepatitis C in Galicia: Results for reflection.
Topics: Female; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Reflex; Retrospective Studies; Viral Load | 2022 |
Towards the elimination of hepatitis C: implementation of reflex testing in Andalusia.
Topics: Hepacivirus; Hepatitis C; Humans; Prospective Studies; Reflex; Retrospective Studies; Spain | 2020 |
Hepatitis C reflex testing in Spain in 2019: A story of success.
Topics: Cross-Sectional Studies; Hepacivirus; Hepatitis C; Humans; Reflex; Spain | 2021 |
Reflex testing. A key tool for the elimination of hepatitis C.
Topics: Antiviral Agents; Hepatitis C; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Reflex | 2020 |
Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA.
Topics: Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Point-of-Care Testing; Reflex; RNA; RNA, Viral | 2021 |
Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community.
Topics: Feasibility Studies; Hepacivirus; Hepatitis C; Humans; Reflex; RNA, Viral; Sensitivity and Specificity; Silver; Taiwan | 2021 |
Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study.
Topics: Cohort Studies; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Humans; Prospective Studies; Reflex; Taiwan | 2021 |